Pharma

Jun 22 2018

Best Brands, pharma brands.#Pharma #brands

Best Brands Best Global Taiwan Brands 2017 Best Global Brands Best Asia Brands Interbrand Breakthrough Brands Best China Brands Best Korea Brands Best Japan Brands Best Global Brands Best Brazilian Brands Best Indian Brands Interbrand Breakthrough Brands Best Swiss Brands Best Korea Brands (English) Best Pharma Brands Best Japan Brands (Japanese) Best Spanish Brands (Spanish) Best Indian Brands Best Global Brands Best Dutch Insurance Brands (Dutch) Best German Brands Best Swiss Brands Best Korean Brands (English) Best Korean Brands (Korean) Best Dutch Media Brands (Dutch) Best Japan Brands (Japanese) Best Global Brands Best Japan Brands (English) Best Global Green Brands …

Mar 9 2018

PharmaTimes – in-depth news, features and insights for the pharmaceutical and healthcare sectors, pharma brands.#Pharma #brands

Web Exclusives Stopping antibiotic resistance This Antibiotic Awareness Week, Thomas Cueni, chair of the AMR Industry Alliance, gives some practical steps to stop one of the biggest medical threats in the world A new OECD gold standard for lethal injection drugs The latest developments in a controversial area of the pharma industry Harnessing patient communities Why online communities are so important to both patients and pharma Wish you were here? Why UK expats in former British colonies are not missing the NHS Magazine Patient Files: Ulcerative colitis Charlotte Guinea talks about her experiences with this invisible disease What science really …

Dec 24 2017

Sun Pharmaceuticals to sell some low priority Ranbaxy brands – The Economic Times #watson #pharma

#sun pharma products # Sun Pharmaceuticals to sell some low priority Ranbaxy brands MUMBAI: Drug maker Sun Pharmaceuticals has put on the block a bundle of Ranbaxy brands which are low priority in its domestic market strategy or which may overlap with its own products, top industry executives said. The country’s largest drug maker completed acquisition of Ranbaxy last year from its Japanese owner, Daiichi Sankyo. as part of a $4 billion all-stock deal. The Ranbaxy brands that Sun is looking to sell rake in about Rs 115 crore in annual sales and the company is expecting a valuation of …

Aug 6 2017

Sun Pharmaceuticals to sell some low priority Ranbaxy brands – The Economic Times #alkem #pharma

#sun pharma products # Sun Pharmaceuticals to sell some low priority Ranbaxy brands MUMBAI: Drug maker Sun Pharmaceuticals has put on the block a bundle of Ranbaxy brands which are low priority in its domestic market strategy or which may overlap with its own products, top industry executives said. The country’s largest drug maker completed acquisition of Ranbaxy last year from its Japanese owner, Daiichi Sankyo. as part of a $4 billion all-stock deal. The Ranbaxy brands that Sun is looking to sell rake in about Rs 115 crore in annual sales and the company is expecting a valuation of …

Jul 31 2017

Sun Pharmaceuticals to sell some low priority Ranbaxy brands – The Economic Times #pharma #executive #search

#sun pharma products # Sun Pharmaceuticals to sell some low priority Ranbaxy brands MUMBAI: Drug maker Sun Pharmaceuticals has put on the block a bundle of Ranbaxy brands which are low priority in its domestic market strategy or which may overlap with its own products, top industry executives said. The country’s largest drug maker completed acquisition of Ranbaxy last year from its Japanese owner, Daiichi Sankyo. as part of a $4 billion all-stock deal. The Ranbaxy brands that Sun is looking to sell rake in about Rs 115 crore in annual sales and the company is expecting a valuation of …

Jun 11 2017

Sun Pharmaceuticals to sell some low priority Ranbaxy brands – The Economic Times #pharma #engineering

#sun pharma products # Sun Pharmaceuticals to sell some low priority Ranbaxy brands MUMBAI: Drug maker Sun Pharmaceuticals has put on the block a bundle of Ranbaxy brands which are low priority in its domestic market strategy or which may overlap with its own products, top industry executives said. The country’s largest drug maker completed acquisition of Ranbaxy last year from its Japanese owner, Daiichi Sankyo. as part of a $4 billion all-stock deal. The Ranbaxy brands that Sun is looking to sell rake in about Rs 115 crore in annual sales and the company is expecting a valuation of …

Apr 16 2017

Sun Pharmaceuticals to sell some low priority Ranbaxy brands – The Economic Times #pharma #projects

#sun pharma products # Sun Pharmaceuticals to sell some low priority Ranbaxy brands MUMBAI: Drug maker Sun Pharmaceuticals has put on the block a bundle of Ranbaxy brands which are low priority in its domestic market strategy or which may overlap with its own products, top industry executives said. The country’s largest drug maker completed acquisition of Ranbaxy last year from its Japanese owner, Daiichi Sankyo. as part of a $4 billion all-stock deal. The Ranbaxy brands that Sun is looking to sell rake in about Rs 115 crore in annual sales and the company is expecting a valuation of …

Mar 28 2017

Sun Pharmaceuticals to sell some low priority Ranbaxy brands – The Economic Times #contract #pharmaceutical #companies

#sun pharma products # Sun Pharmaceuticals to sell some low priority Ranbaxy brands MUMBAI: Drug maker Sun Pharmaceuticals has put on the block a bundle of Ranbaxy brands which are low priority in its domestic market strategy or which may overlap with its own products, top industry executives said. The country’s largest drug maker completed acquisition of Ranbaxy last year from its Japanese owner, Daiichi Sankyo. as part of a $4 billion all-stock deal. The Ranbaxy brands that Sun is looking to sell rake in about Rs 115 crore in annual sales and the company is expecting a valuation of …

Feb 10 2017

Sun Pharmaceuticals to sell some low priority Ranbaxy brands – The Economic Times #astellas #pharma

#sun pharma products # Sun Pharmaceuticals to sell some low priority Ranbaxy brands MUMBAI: Drug maker Sun Pharmaceuticals has put on the block a bundle of Ranbaxy brands which are low priority in its domestic market strategy or which may overlap with its own products, top industry executives said. The country’s largest drug maker completed acquisition of Ranbaxy last year from its Japanese owner, Daiichi Sankyo. as part of a $4 billion all-stock deal. The Ranbaxy brands that Sun is looking to sell rake in about Rs 115 crore in annual sales and the company is expecting a valuation of …

Jan 21 2017

Sun Pharmaceuticals to sell some low priority Ranbaxy brands – The Economic Times #pharma #industries

#sun pharma products # Sun Pharmaceuticals to sell some low priority Ranbaxy brands MUMBAI: Drug maker Sun Pharmaceuticals has put on the block a bundle of Ranbaxy brands which are low priority in its domestic market strategy or which may overlap with its own products, top industry executives said. The country’s largest drug maker completed acquisition of Ranbaxy last year from its Japanese owner, Daiichi Sankyo. as part of a $4 billion all-stock deal. The Ranbaxy brands that Sun is looking to sell rake in about Rs 115 crore in annual sales and the company is expecting a valuation of …